10720289

Source:http://linkedlifedata.com/resource/pubmed/id/10720289

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0024485, umls-concept:C0092801, umls-concept:C0205210, umls-concept:C0205329, umls-concept:C1257890, umls-concept:C1274040, umls-concept:C2587213, umls-concept:C2603343
pubmed:issue	5
pubmed:dateCreated	2000-6-28
pubmed:abstractText	To evaluate the safety and efficacy of two doses of cladribine in patients with progressive MS.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cladribine
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0028-3878
pubmed:author	pubmed-author:ComiGG, pubmed-author:FilippiMM, pubmed-author:UNNOTT
pubmed:issnType	Print
pubmed:day	14
pubmed:volume	54
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1145-55
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10720289-Adult, pubmed-meshheading:10720289-Cladribine, pubmed-meshheading:10720289-Double-Blind Method, pubmed-meshheading:10720289-Female, pubmed-meshheading:10720289-Humans, pubmed-meshheading:10720289-Magnetic Resonance Imaging, pubmed-meshheading:10720289-Male, pubmed-meshheading:10720289-Multiple Sclerosis
pubmed:year	2000
pubmed:articleTitle	Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group.
pubmed:affiliation	University Hospital, University of Western Ontario, London, Canada. grice@julian.uwo.ca
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study